Sun, 28 Sep 2025

Sun, 28 Sep 2025 How weight-loss injections are turning obesity into a wealth issue

With claims of a 'two-tier system', could it be that these drugs are exacerbating health inequalities?
1. Weight loss jabs are expensive: Weight loss treatments, such as Ozempic (semaglutide), can be costly for the NHS, with prices ranging from £50 to £100 per injection. 2. NHS access is limited: Currently, only those with a BMI of 40 or higher can get free weight loss jabs on the NHS. This excludes many people who could benefit from treatment. 3. Black market risks: Some people are turning to black markets or unscrupulous services to obtain weight loss treatments without proper medical assessment or follow-up. 4. Side effects and safety concerns: There have been reports of serious side effects, including pancreatitis, associated with weight loss jabs. 5. Prevention vs treatment: Experts argue that prevention is key, and the NHS should focus on addressing the root causes of obesity, such as a "broken food system" and poor diet options in disadvantaged areas. 6. Cost savings: Obesity costs the economy £98 billion per year, and some experts suggest that providing weight loss treatments to those with BMIs over 27 could be cost-effective in the long run. The article also highlights the complexities of addressing obesity as a society-wide issue, requiring changes to our food system, regulation, and public health policies. Experts caution against focusing solely on medicalizing obesity, as this can distract from the broader social and economic factors contributing to the problem. Some potential solutions proposed: 1. Widening NHS access: Offering weight loss treatments to more people, including those with BMIs over 27. 2. Means-tested system: Providing free treatment to those entitled to it, while others self-fund or receive support from employers. 3. Prevention and education: Investing in public health campaigns and initiatives that promote healthy eating, physical activity, and lifestyle changes. Overall, the article highlights the need for a more comprehensive approach to addressing obesity, one that tackles its root causes rather than just treating its symptoms.
  >>